tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
uniQure’s AMT-130: Promising Results Amid Regulatory Challenges Support Buy Rating
PremiumRatingsuniQure’s AMT-130: Promising Results Amid Regulatory Challenges Support Buy Rating
19d ago
uniQure’s AMT-130: A Promising Breakthrough in Huntington’s Disease Treatment Amidst Regulatory Challenges
Premium
Ratings
uniQure’s AMT-130: A Promising Breakthrough in Huntington’s Disease Treatment Amidst Regulatory Challenges
19d ago
uniQure price target lowered to $60 from $68 at Leerink
Premium
The Fly
uniQure price target lowered to $60 from $68 at Leerink
19d ago
uniQure price target lowered to $38 from $56 at Goldman Sachs
PremiumThe FlyuniQure price target lowered to $38 from $56 at Goldman Sachs
25d ago
uniQure price target lowered to $70 from $110 at H.C. Wainwright
Premium
The Fly
uniQure price target lowered to $70 from $110 at H.C. Wainwright
25d ago
William Blair downgrades uniQure on uncertain path forward
Premium
The Fly
William Blair downgrades uniQure on uncertain path forward
25d ago
Video: What is dragging down Biohaven today
PremiumThe FlyVideo: What is dragging down Biohaven today
26d ago
Truist sees no read-throughs to PTC, Wave Life from uniQure news
Premium
The Fly
Truist sees no read-throughs to PTC, Wave Life from uniQure news
26d ago
uniQure falls -50.2%
Premium
The Fly
uniQure falls -50.2%
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100